About Inger Therapeutics
Inger Therapeutics is a company based in Chennai (India) founded in 2021 by Bala Yeshwanth Ram Vummidi. Inger Therapeutics operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter Chennai, India
- Founders Bala Yeshwanth Ram Vummidi
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inger Therapeutics Private Limited
- Date of Incorporation 28 Oct, 2021
- Jurisdiction Tiruvallur, Tamil Nadu, India
-
Annual Revenue
Not available
-
Net Profit
-$532.3 (USD)0as on Mar 31, 2022
-
EBITDA
-$532.3 (USD)0as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Inger Therapeutics
Investors in Inger Therapeutics
Inger Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include StartupTN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Potato farming, grain marketing, and equipment services in Maine.
|
Locked | Locked | Locked |
Investor details for Inger Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inger Therapeutics
Investment portfolio details for Inger Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inger Therapeutics
Detailed financials for Inger Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inger Therapeutics Comparisons
Peer comparison for Inger Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inger Therapeutics
Inger Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Technology for antibody-drug conjugation is provided by AbTis.
|
Detailed competitors of Inger Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inger Therapeutics
Complete news archive for Inger Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inger Therapeutics
Inger Therapeutics was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Inger Therapeutics is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Inger Therapeutics was established in 2021 in Chennai, India, within the biotechnology sector. Peptide-based ligands, termed Suprabodies, are created using innovative screening methods. These ligands are supplied to pharmaceutical companies, biotechnology organizations, and academic institutions to support ligand discovery for therapeutic and research purposes. Operations focus on addressing needs in drug development and scientific applications.
Inger Therapeutics's top competitors include Sino Biological, GenScript and Y-Biologics.
Inger Therapeutics has 1 investor. Key investors include StartupTN.